+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Sleep Aids in Egypt

  • ID: 1233525
  • Report
  • September 2016
  • Region: Egypt
  • 19 pages
  • Euromonitor International
1 of 4
Sales of sleep aids remained low in Egypt in 2016 because the usage of such products is still perceived negatively and treated as a taboo. Unless the insomnia being experienced is extreme and needs the attention of a doctor, the majority of Egyptians will not use sleep aids. In addition, most of the brands available in the category are expensive and thus purchased only by upper-income consumers.

The Sleep Aids in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Sleep Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 4

Loading
LOADING...

3 of 4
SLEEP AIDS IN EGYPT

September 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Sleep Aids: Value 2011-2016
Table 2 Sales of Sleep Aids: % Value Growth 2011-2016
Table 3 NBO Company Shares of Sleep Aids: % Value 2012-2016
Table 4 LBN Brand Shares of Sleep Aids: % Value 2013-2016
Table 5 Forecast Sales of Sleep Aids: Value 2016-2021
Table 6 Forecast Sales of Sleep Aids: % Value Growth 2016-2021
Mepaco (arab Co for Pharmaceuticals & Medicinal Plants) in Consumer Health (egypt)
Strategic Direction
Key Facts
Summary 1 MEPACO (Arab Co for Pharmaceuticals and Medicinal Plants): Key Facts
Competitive Positioning
Summary 2 MEPACO (Arab Co for Pharmaceuticals and Medicinal Plants): Competitive Position 2016
Executive Summary
2016 Is Marked by Crisis in Consumer Health in Egypt
Trading Environment Is Unattractive for International Companies and Newcomers
A Self-medication Culture in Which Almost All Consumer Health Products Are Sold OTC
Dynamic Value Growth Expected As Unit Prices Are Set To Increase
Key Trends and Developments
Consumer Health Crisis Linked To the Adverse US Dollar Exchange Rate Situation
Rigid Control Maintained by the Ministry of Health
Self-medication Remains the Major Driver of Sales in Consumer Health
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 8 Life Expectancy at Birth 2011-2016
Market Data
Table 9 Sales of Consumer Health by Category: Value 2011-2016
Table 10 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 11 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 12 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 13 Distribution of Consumer Health by Format: % Value 2011-2016
Table 14 Distribution of Consumer Health by Format and Category: % Value 2016
Table 15 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 3 Research Sources
Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll